Should You Buy, Sell, or Hold Synchrony Financial Stock at a 10.26X P/E?
ZACKS· 2025-01-21 16:50
Synchrony Financial (SYF) stock is currently trading at a notable discount relative to the Zacks Financial Miscellaneous Servicesindustry. With a forward 12-month price-to-earnings (P/E) ratio of 10.26, it sits well below the industry average of 16.18. The company has a Value Score of A.Image Source: Zacks Investment ResearchIn comparison, companies like Bread Financial Holdings, Inc. (BFH) and StoneX Group Inc. (SNEX) are trading at a P/E ratio of 9.31 and 12.94, respectively. Given SYF’s valuation, we nee ...
DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?
ZACKS· 2025-01-21 16:50
DexCom Inc. (DXCM) is off to a strong start in 2025, with its stock rallying 5.7% following the release of its preliminary results for the fourth quarter and fiscal 2024 on Jan. 13, 2025. The company’s robust performance has reaffirmed investor confidence, driven by impressive revenue growth and a promising outlook for 2025. The upbeat results demonstrate DexCom’s position as a key player in the continuous glucose monitoring (CGM) market.The preliminary report highlighted fourth-quarter fiscal 2024 total re ...
Navient To Benefit From New Trump Administration? Analyst Turns Bullish
Benzinga· 2025-01-21 16:47
Navient Corp NAVI ended the third quarter with an adjusted cash position of $572 million, or $5.35 per share.That’s adjusted for an unsecured debt maturity and $65 million worth of share repurchases expected in the fourth quarter, according to Seaport Research Partners.The Navient Analyst: Analyst Bill Ryan upgraded the rating for Navient from Neutral to Buy, while establishing a price target of $18.The Navient Thesis: The consumer lending segment is valued at 7X of the 2025 estimate for the company, or $12 ...
Waste Management Stock is Consolidating: Buy, Hold, or Sell?
ZACKS· 2025-01-21 16:46
Waste Management, Inc. (WM) has remained stagnant over the past 10 months, showing no stock price growth, while the industry posted a modest 2.7% gain.The company’s performance lags behind key competitors such as Republic Services (RSG) , which experienced a 12% rise, and Clean Harbors (CLH) , which surged 24% during the same period.Given the consolidation, let's explore the factors shaping WM’s performance and evaluate whether this is an opportune moment to invest in the company.Over the years, WM has show ...
DXP Enterprises is Trading Near 52-Week High: Should You Buy the Stock?
ZACKS· 2025-01-21 16:46
Shares of DXP Enterprises, Inc. (DXPE) have been showing impressive gains of late, trading close to its 52-week high of $103.61. The stock closed at $102.67 on Friday, 0.9% below the highest point. Shares of the maintenance, repair and operating (MRO) products distributor have surged 97.2% in the past six months, outpacing the Zacks sub-industry’s and the S&P 500’s growth of 3.4% and 8.2%, respectively.The company has also outperformed other industry players like Ingersoll Rand Inc. (IR) and Xylem Inc. (XYL ...
ERIC Boosts Three UK's Network With Advanced Solutions: Stock to Gain?
ZACKS· 2025-01-21 16:46
Ericsson (ERIC) recently announced that it has been selected by the British telecommunications company, Three UK, to develop its next-generation, cloud-native core network. This collaborative effort aims to more than triple Three UK’s core capacity to 9 terabits per second (Tbps), positioning the upgraded network as the largest of its kind in Europe.Digging Deep Into ERIC- Three UK CollaborationAn exponential growth in streaming services, gaming and home broadband has led to a surge in data traffic. Data u ...
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study
ZACKS· 2025-01-21 16:46
Nanobiotix (NBTX) shares were up around 13% during the pre-market hours on Tuesday after the company announced that it has initiated dosing in a mid-stage study evaluating a potential first-in-class radioenhancer, JNJ-1900 (NBTXR3), to treat lung cancer patients. The candidate was added to Nanobiotix’s pipeline following a licensing deal for the global co-development and commercialization with pharma bigwig, Johnson & Johnson (JNJ) , in 2023.The company stated that it has dosed the first patient with JNJ-19 ...
IBM, L'Oreal Team Up to Drive Sustainable Innovation With AI Model
ZACKS· 2025-01-21 16:46
International Business Machines Corporation (IBM) recently announced that L'Oreal has opted to deploy its state-of-the-art generative artificial intelligence (AI) technology solutions to enhance its cosmetic formulation processes. By combining its deep expertise in cosmetic science with IBM's advanced technology, the world’s leading beauty company is set to develop a custom AI foundation model to uncover new insights that will drive the development of more sustainable beauty products while reducing material ...
The New York Times Trades at a Discount: Is It a Buying Opportunity?
ZACKS· 2025-01-21 16:46
The New York Times Company (NYT) , a diversified media powerhouse, is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 25.19, positioning it at a discount relative to the industry average of 27.69. This valuation raises a crucial question: Is the stock an undervalued opportunity for investors, or does it reflect underlying challenges that warrant caution?NYT Trading at a DiscountImage Source: Zacks Investment ResearchShares of The New York Times Company have declined 5.2% over the pa ...
Carvana Co. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
ACCESSWIRE Newsroom· 2025-01-21 16:45
Carvana Co. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm ...